02 May 2003
PARP inhibitors modulate upregulation of uPA gene expression in transformed endothelial cells
R. Caldini, L. Ciarpallini, M. Del Rosso, E. Barletta, M. ChevanneMed Sci Monit 2003; 9(1): 6-0 :: ID: 14991
Abstract
Tumor growth and metastasis are complex processes which involve cell adhesion, proteolytic degradation of extracellular matrix and basement membrane, and cell migration. Several studies have demonstrated a pivotal role of the urokinase-type plasminogen activator (uPA) system in tumor growth, angiogenesis, and metastasis. In fact uPA and uPA receptor (uPAR) are overexpressed by many tumors and their expression correlates with tumor progression and poor prognosis, while downregulation of uPA or uPAR reduces invasiveness and tumorigenesis. In this study we demonstrate that FGF2 upregulation of uPA gene expression is mediated by poly(ADP-ribose) polymerase(PARP) activity. In fact. A specific inhibitor of PARP activity such as 3-aminobenzamide, as well as NAD+ deprivation, prevents FGF2-mediated uPA gene upregulation and cell-associated uPA production in transformed foetal bovine aortic endothelial cells GM7373. We also provide evidence that FGF2 enhances PARP activity by MAPK-dependent phosphorylation. It is noteworthy that also uPA-uPAR interaction controls uPA production through MAPK-dependent activation.Identification of the pathway which modulates upregulation of uPA gene expression, following MAPK activation, may be a new therapeutic target in anticancer therapy. In particular drugs which inhibit PARP activity could be relevant in the control of tumor angiogenesis and metastasis.
Keywords: PARP, uPA, FGF2, MAPK, GM7373 cells
309 0
Editorial
01 June 2023 : Editorial
Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic PreparednessDOI: 10.12659/MSM.941209
Med Sci Monit 2023; 29:e941209
In Press
08 Jun 2023 : Clinical Research
Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...Med Sci Monit In Press; DOI: 10.12659/MSM.940134
08 Jun 2023 : Clinical Research
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...Med Sci Monit In Press; DOI: 10.12659/MSM.940124
08 Jun 2023 : Clinical Research
Burden of COVID-19 on Mental Health of Resident Doctors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940208
08 Jun 2023 : Clinical Research
Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...Med Sci Monit In Press; DOI: 10.12659/MSM.940251
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952